Mercer Global Advisors Inc Astrazeneca PLC Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $624,284 - $698,827	-10,087 Reduced 7.15%	130,929 $8.82 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $1.2 Million - $1.32 Million	18,453 Added 15.06%	141,016 $9.55 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $433,791 - $470,401	6,205 Added 5.33%	122,563 $8.77 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $15,029 - $17,040	238 Added 0.2%	116,358 $8.08 Million
Q4 2022 Feb 08, 2023	BUY	$54.21 - $70.44 $896,633 - $1.17 Million	16,540 Added 16.61%	116,120 $7.87 Million
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $12,883 - $32,987	243 Added 0.24%	99,580 $5.46 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $328,478 - $394,329	5,543 Added 5.91%	99,337 $6.56 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $248,009 - $298,751	4,451 Added 4.98%	93,794 $6.22 Million
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $609,075 - $719,683	11,275 Added 14.44%	89,343 $5.2 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $1.77 Million - $1.94 Million	31,939 Added 69.24%	78,068 $4.69 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $352,933 - $438,652	7,289 Added 18.77%	46,129 $2.76 Million
Q1 2021 Aug 10, 2021	BUY	$47.16 - $54.44 $13,865 - $16,005	294 Added 0.76%	38,840 $1.93 Million
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $231,744 - $267,518	4,914 Added 14.61%	38,546 $1.92 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $50,800 - $60,746	-1,047 Reduced 3.02%	33,632 $1.68 Million
Q3 2020 Dec 10, 2020	BUY	$53.07 - $61.1 $250,225 - $288,086	4,715 Added 15.74%	34,679 $1.9 Million
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $13,792 - $17,699	320 Added 1.08%	29,964 $1.59 Million
Q1 2020 May 18, 2020	BUY	$37.79 - $51.33 $107,966 - $146,649	2,857 Added 10.67%	29,644 $1.32 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $83,985 - $99,809	1,978 Added 7.97%	26,787 $1.34 Million
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $154,863 - $175,514	3,860 Added 18.43%	24,809 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $59,498 - $66,521	1,596 Added 8.25%	20,949 $865,000
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $715,620 - $867,455	-20,164 Reduced 51.03%	19,353 $782,000
Q1 2019 Apr 12, 2019	BUY	$35.49 - $43.02 $1.4 Million - $1.7 Million	39,517 New	39,517 $1.5 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.11 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.74 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.43 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.41 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.25 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account